Amphastar P (AMPH)
Total asset turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 644,395 | 601,313 | 540,886 | 518,641 | 498,987 | 484,851 | 476,920 | 455,116 | 437,768 | 412,802 | 384,035 | 368,178 | 349,846 | 337,308 | 334,014 | 327,255 | 322,357 | 328,664 | 324,070 | 316,063 |
Total assets | US$ in thousands | 1,512,910 | 1,544,630 | 1,378,270 | 773,656 | 741,987 | 726,695 | 723,719 | 716,238 | 671,529 | 651,677 | 665,745 | 645,738 | 631,236 | 613,718 | 600,058 | 572,831 | 586,971 | 585,636 | 601,301 | 544,718 |
Total asset turnover | 0.43 | 0.39 | 0.39 | 0.67 | 0.67 | 0.67 | 0.66 | 0.64 | 0.65 | 0.63 | 0.58 | 0.57 | 0.55 | 0.55 | 0.56 | 0.57 | 0.55 | 0.56 | 0.54 | 0.58 |
December 31, 2023 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $644,395K ÷ $1,512,910K
= 0.43
The total asset turnover ratio of Amphastar Pharmaceuticals Inc has shown fluctuations over the past eight quarters. The ratio ranged from 0.39 to 0.67 during this period, indicating how efficiently the company is generating revenue from its total assets. A lower ratio suggests that the company is less efficient in generating sales from its assets, while a higher ratio indicates a better utilization of assets to generate revenue.
In the most recent quarter (Q4 2023), the total asset turnover ratio was 0.43, which reflects a decrease from the previous quarter's ratio of 0.39. This decrease may suggest that the company's asset management and utilization in revenue generation may have weakened during this period.
On the other hand, there were quarters such as Q1 2023 and Q4 2022 where the total asset turnover ratio was relatively higher at 0.67. During these periods, Amphastar Pharmaceuticals Inc demonstrated better efficiency in utilizing its assets to generate revenue.
Overall, it would be advisable for stakeholders to closely monitor the trend of the total asset turnover ratio to assess the company's efficiency in utilizing assets for revenue generation and to identify any potential areas for improvement in asset management.
Peer comparison
Dec 31, 2023